Alnylam Pharma (ALNY) Tops Q4 EPS by 32c
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $301.67 +0.21%
EPS Growth %: +409.4%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: +409.4%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($0.28), $0.32 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $24.02 million versus the consensus estimate of $13.1 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $470 at H.C. Wainwright
- Goldman Sachs initiates FedEx Freight with Buy, sees 23% margin expansion upside
- Columbus McKinnon names John Linker as CFO, reaffirms FY2027 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
